Process for the preparation of 4-(6-chloro-2, 3-methylenedioxyanilino)-7-(2-(4-methyl piperazin-1-yl) ethoxy)-5-tetrahydropyran-4-yloxyquinazoli ne, their intermediates and crystalline salts thereof

Details for Australian Patent Application No. 2005315458 (hide)

Owner AstraZeneca AB

Inventors Ford, James Gair; Purdie, Mark; Pointon, Simon Mark; O'Kearney-McMullan Anne; Withnall, Jane; Powell, Lyn; McCabe, James Francis; O'Keefe, Philip

Agent Davies Collison Cave

Pub. Number AU-B-2005315458

PCT Pub. Number WO2006/064217

Priority 0427697.8 17.12.04 GB

Filing date 14 December 2005

Wipo publication date 22 June 2006

Acceptance publication date 12 March 2009

International Classifications

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/064217 Priority application(s): WO2006/064217

12 March 2009 Application Accepted

  Published as AU-B-2005315458

9 July 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005315459-Hydantoin derivatives useful as metalloproteinase inhibitors

2005315456-Axially energisable ball valve